Order Now For Fast Delivery!
This website uses cookies to enhance the user experience. Some cookies are essential for the use of the site. View our Privacy Policy and Cookie Policy for more information.
Darlene Petersen, MD and Paula Cook, MD
Darlene Petersen, MD and Paula Cook, MD
Higher Dose Buprenorphine in Treatment Retention: Fentanyl Considerations
Higher Dose Buprenorphine in Treatment Retention: Fentanyl Considerations
Wednesday 15th November 2023
Drs. Petersen and Cook explore higher buprenorphine doses for fentanyl addiction, discussing their impact on treatment retention and personalized care.
Explicit
33 minutes
Thought-provoking
Informative
Empowering
Transformative
Hopeful
About this podcast
Author:
Darlene Petersen, MD and Paula Cook, MD
Overview:
Darlene Petersen, MD and Paula Cook, MD are board certified addiction medicine and family medicine physicians providing evidence based education, clinical pearls and resources to physicians, residents...(view more)
Categories:
Understanding Addiction & Recovery
Navigating Alcohol Dependency
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Family Recovery from Addiction
Links:
Visit site
Episodes:
98 (View all)
Do you want to link to this podcast?
Get the buttons here!Buprenorphine and Fentanyl: Rethinking Opioid Treatment Strategies
Episode Overview
- The study examines the trend of higher doses for fentanyl and the initiation of buprenorphine in treating opioid use disorder.
- Considerations are discussed regarding the potential need for higher doses of buprenorphine in the context of fentanyl's unique properties and rapid physiological dependence.
- The limitations and implications of the study are explored, shedding light on the complexities of treating opioid use disorder in the current landscape.
- Key takeaways include insights into personalized treatment plans, retention strategies, and the challenges in addiction medicine, prompting critical conversations in the field.
- The episode offers valuable considerations for healthcare professionals, patients, and individuals interested in the latest developments in addiction medicine.
Even without best treatment, we have over half of the people leaving treatment in six months. Buprenorphine and methadone aren't equally as good as each other. And that's pretty much what we've got. We're looking at a really serious, chronically relapsing, deadly condition, opioid use disorder.
When it comes to treating opioid use disorder, the game has changed with the rise of fentanyl. In this episode of 'The Addiction Files', Dr. Darlene Petersen and Dr. Paula Cook tackle a pressing issue: how do higher doses of buprenorphine affect treatment retention for patients grappling with fentanyl addiction?
Drawing from the study 'Buprenorphine Dose and Time to Discontinuation Among Patients With Opioid Use Disorder in the Era of Fentanyl', our hosts dive into the nuances of managing high-dose synthetic opioids. This isn’t just a clinical discussion; it’s a vital conversation about adapting treatment plans to meet the evolving challenges of opioid addiction. Whether you're a healthcare professional, a patient, or someone interested in the latest in addiction medicine, this episode offers a wealth of insights.
From the need for personalized treatment plans to the study's limitations and broader implications, Drs. Petersen and Cook guide you through the complexities with clarity and compassion. Tune in for an enlightening discussion that could reshape your understanding of opioid treatment strategies.